Get 20% lifetime commission for referring investors to digrin.com
here.
Photocure ASA (PHCUF) Financials
PHCUF Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 90.9 million | 29.7 million |
| March 31, 2026 | 80.3 million | 21.3 million |
| Dec. 31, 2025 | 70.2 million | 22.1 million |
| Sept. 30, 2025 | 69.4 million | 20.9 million |
PHCUF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | 5.8 million | 363138 |
| March 31, 2026 | -678466 | 442398 |
| Dec. 31, 2025 | 1.6 million | 472706 |
| Sept. 30, 2025 | 2.1 million | ? |
PHCUF Net Income
Graph available only for paid members. Upgrade to see it.
| Date | Net Income |
|---|---|
| June 30, 2026 | -170271 |
| March 31, 2026 | 11.2 million |
| Dec. 31, 2025 | -789617 |
| Sept. 30, 2025 | 396950 |
PHCUF Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 16.4 million | - | - |
| March 31, 2026 | 19.8 million | - | - |
| Dec. 31, 2025 | 23.7 million | - | 1.0 million |
| Sept. 30, 2025 | 24.7 million | - | 1.2 million |
PHCUF Shares Outstanding
PHCUF Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 523121 | 53809 | 8.6 million | - |
| March 31, 2026 | 757564 | 54060 | 9.7 million | 9.7 million |
| Dec. 31, 2025 | 1.4 million | -41098 | 10.3 million | 9.9 million |
| Sept. 30, 2025 | 1.1 million | -100088 | 8.6 million | - |
PHCUF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 14.3 million | 1.8 million |
| March 31, 2026 | 27.0 million | 1.1 million |
| Dec. 31, 2025 | 13.6 million | 1.1 million |
| Sept. 30, 2025 | 13.5 million | 1.9 million |
PHCUF
Price: $5.65
52 week price:
Dividend Yield: 5.70%
Payout Ratio Range:
Earnings Per Share: 0.30 USD
P/E Ratio: 20.03
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 150.3 million